Fcpm III Services B.v.
Fcpm III Services B.v. reported 15 stocks worth $1.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. Its largest holdings are BRVE (41.6%), NAMS (19.5%) and KRSA (6.6%). Compared with Q2 2026, the fund opened new positions in BRVE, KRSA and TARS, added to MPLT, AURA and CBIO and trimmed VOR, DYN and REPL.
Latest filing: what Fcpm III Services B.v. did in Q3 2026
vs Q2 2026None
Dollar changes use the share change at the quarter end price. New and sold out show the whole position.
Portfolio at a glance
share of reported value · Q3 2026Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 | ![]() BRVE Braveheart Bio Inc | $441M | 41.6% | 21.8M | New position | 1 of 8 | |
| 2 | ![]() NAMS Newamsterdam Pharma Company | $206M | 19.5% | 8.5M | No change | 8 of 8 | |
| 3 | ![]() KRSA Korsana Biosciences Inc | $70.1M | 6.6% | 2.2M | New position | 1 of 8 | |
| 4 | ![]() VOR Vor Biopharma Inc Com New | $65M | 6.1% | 3.4M | −712K (−17%) | 5 of 8 | |
| 5 | ![]() DYN Dyne Therapeutics Inc | $57.8M | 5.5% | 3.6M | −261K (−7%) | 8 of 8 | |
| 6 | GALECTO INC | $51.9M | 4.9% | 2.4M | No change | 3 of 8 | |
| 7 | ![]() MPLT Maplight Therapeutics Inc | $45.1M | 4.3% | 4.4M | +1.2M (+37%) | 4 of 8 | |
| 8 | ![]() AURA Aura Biosciences Inc | $33M | 3.1% | 5.2M | +1.2M (+29%) | 2 of 8 | |
| 9 | ![]() CBIO Crescent Biopharma Inc. | $29.5M | 2.8% | 2M | +345K (+21%) | 4 of 8 | |
| 10 | ![]() REPL Replimune Group Inc | $22.8M | 2.1% | 1.7M | −1.1M (−39%) | 8 of 8 |
Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q3 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Nov 16, 2026 | 13F-HR | Q3 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Fcpm III Services B.v. 13F FAQ
What does Fcpm III Services B.v. own?
Fcpm III Services B.v. reported 15 stocks worth $1.1B in its 13F filing for Q3 2026, filed Nov 16, 2026. The table above lists every position in the filing (the top 10 without an account).
What did Fcpm III Services B.v. buy and sell in Q3 2026?
Compared with Q2 2026: 4 new positions, 3 added to, 3 trimmed and 0 sold out. New positions include BRVE, KRSA and TARS.
When will Fcpm III Services B.v. file its next 13F?
Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.
How much is Fcpm III Services B.v.'s portfolio worth?
The Q3 2026 filing reports $1.1B in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.










